Correlation Between Takeda Pharmaceutical and Abcellera Biologics

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical Co and Abcellera Biologics, you can compare the effects of market volatilities on Takeda Pharmaceutical and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Abcellera Biologics.

Diversification Opportunities for Takeda Pharmaceutical and Abcellera Biologics

-0.79

Correlation Coefficient

Takeda Pharmaceutical  Abcellera Biologics

Pay attention - limited upside

The 3 months correlation between Takeda and Abcellera is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Abcellera Biologics go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Abcellera Biologics

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.25 times more return on investment than Abcellera Biologics. However, Takeda Pharmaceutical Co is 4.03 times less risky than Abcellera Biologics. It trades about 0.2 of its potential returns per unit of risk. Abcellera Biologics is currently generating about -0.04 per unit of risk. If you would invest  1,317  in Takeda Pharmaceutical Co on December 29, 2024 and sell it today you would earn a total of  188.00  from holding Takeda Pharmaceutical Co or generate 14.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Takeda Pharmaceutical Co  vs.  Abcellera Biologics

Takeda Pharmaceutical

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical Co are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Takeda Pharmaceutical disclosed solid returns over the last few months and may actually be approaching a breakup point.

Abcellera Biologics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Abcellera Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Takeda Pharmaceutical and Abcellera Biologics

The main advantage of trading using opposite Takeda Pharmaceutical and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.

The idea behind Takeda Pharmaceutical Co and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.